About Theracell
Theracell is a company based in London (United Kingdom) founded in 2012 was acquired by ISTO Biologics in April 2022.. Theracell operates in a competitive market with competitors including Univercells, Sutro Biopharma, Tenaya Therapeutics, GSK and Straumann Group, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Theracell Advanced Biotechnology (Belgium)
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
ISTO Biologics
(Apr 06, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Theracell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Theracell
Theracell has secured backing from 1 investor. Prominent investors backing the company include ISTO Biologics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of treatments for cartilage and bone problems
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Theracell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Theracell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theracell Comparisons
Competitors of Theracell
Theracell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Univercells, Sutro Biopharma, Tenaya Therapeutics, GSK and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
Acquisition and development of scientific instrument businesses is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theracell
Frequently Asked Questions about Theracell
When was Theracell founded?
Theracell was founded in 2012.
Where is Theracell located?
Theracell is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
What does Theracell do?
Theracell is a biotechnology company developing stem cell and regenerative technology-based solutions to address unmet medical needs. The company has several cellular products in the market for the treatment of scars, and correction of wrinkles called CytoFillers and Cytoprosthetic Hybrids composed of stem cells or fibroblasts and an appropriate matrix to facilitate the growth and differentiation of the cells, migration of additional keratinocytes, revascularization of the affected area, and re-epithelization of the skin. Additionally, the company is developing an autologous stem cell therapy to delay the onset or progression of arthritis using the patients own stem cells, an autologous cultured stem-cell therapy for the treatment of articular cartilage defects (Chondroseal), and FibroLift, an autologous fibroblast-based therapy for cosmetic or aesthetic applications. The company is also developing therapeutics involving superparamagnetic iron oxide nanoparticles that are internalized by stem cells using a poly L-lysine mediated transfection method, following which the stem cells localization within the body can be precisely controlled using magnetic field manipulations. The company is developing therapies for kidney disease and cancer using this technology.
Who are the top competitors of Theracell?
Theracell's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Theracell's investors?
Theracell has 1 investor. Key investors include ISTO Biologics.